Anthony  Hughes net worth and biography

Anthony Hughes Biography and Net Worth

CAO of Amyris
Presently, Anthony Hughes holds the position of Chief Accounting Officer at Amyris, Inc.

In his past career Mr. Hughes held the position of Chief Accounting Officer of ServiceSource International, Inc., Senior Director-Accounting Policy, Reporting & Tax at Blackhawk Network Holdings, Inc., Controller at LECG Corp. and Chief Accounting Officer of CRC Health Corp.

Anthony Hughes received a graduate degree and an undergraduate degree from the University of North Texas.

What is Anthony Hughes' net worth?

The estimated net worth of Anthony Hughes is at least $0.00 as of June 2nd, 2022. Mr. Hughes owns 106,612 shares of Amyris stock worth more than $0 as of November 4th. This net worth evaluation does not reflect any other investments that Mr. Hughes may own. Learn More about Anthony Hughes' net worth.

How do I contact Anthony Hughes?

The corporate mailing address for Mr. Hughes and other Amyris executives is 5885 HOLLIS STREET SUITE 100, EMERYVILLE CA, 94608. Amyris can also be reached via phone at (510) 450-0761 and via email at [email protected]. Learn More on Anthony Hughes' contact information.

Has Anthony Hughes been buying or selling shares of Amyris?

Anthony Hughes has not been actively trading shares of Amyris during the last quarter. Most recently, Anthony Hughes sold 6,305 shares of the business's stock in a transaction on Thursday, June 2nd. The shares were sold at an average price of $2.34, for a transaction totalling $14,753.70. Following the completion of the sale, the chief accounting officer now directly owns 106,612 shares of the company's stock, valued at $249,472.08. Learn More on Anthony Hughes' trading history.

Who are Amyris' active insiders?

Amyris' insider roster includes Eduardo Alvarez (COO), Anthony Hughes (CAO), Nicole Kelsey (Insider), Hermanus Kieftenbeld (CFO), Frank Kung (Director), James McCann (Director), and John Melo (CEO). Learn More on Amyris' active insiders.

Anthony Hughes Insider Trading History at Amyris

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/2/2022Sell6,305$2.34$14,753.70106,612View SEC Filing Icon  
9/2/2021Sell1,162$14.86$17,267.3282,917View SEC Filing Icon  
See Full Table

Anthony Hughes Buying and Selling Activity at Amyris

This chart shows Anthony Hughes's buying and selling at Amyris by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Amyris Company Overview

Amyris logo
Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally. It creates, manufactures, and commercializes consumer products and ingredient, including clean beauty, personal care, and health and wellness consumer products; and ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. The company markets its products under the Biossance, JVN, Rose Inc., Pipette, Costa Brazil, OLIKA, Purecane, Terasana, MenoLabs, EcoFabulous, Stripes, and 4U by Tia brand names. It has a collaboration and license agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California. On August 9, 2023, Amyris, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $0.54
Low: $0.05
High: $1.17

2 Week Range

Now: N/A

Volume

46,746,000 shs

Average Volume

12,593,118 shs

Market Capitalization

$18.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.19